Showing results 1 to 2 of 2
Issue Date | Title | Author(s) |
---|---|---|
2025-04 | KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3+ blast phase chronic myeloid leukemia | Kwon, Hyun-Jin; Shin, Ji Eun; Khan, Amir; Park, So Yeon; Kim, Jiyoung; Lee, Jee-Young; Lee, Doohyun; Lee, Seungyeon; Im, Chun Young; Moon, Heegyum; Han, Ye Ri; Tamai, Minori; Akahane, Koshi; Inukai, Takeshi; Lee, Wonhwa; Kim, Hyelim; Kim, Hong Nam; Ahn, Sung-Min; Park, Hyun Woo; Kim, Dong-Wook |
2023-11 | Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia | Shin, Ji Eun; Kim, Soo-Hyun; MinGyu Kong; Kim, Hwa-Ryeon; Yoon, Sungmin; Kee, Kyung-Mi; Kim, Jung Ah; Kim, Dong Hyeon; Park, So Yeon; Park, Jae Hyung; Kim, Hongtae; No, Kyoung Tai; Lee, Han-Woong; Gee, Heon Yung; Hong, Seunghee; Guan, Kun-Liang; Roe, Jae-Seok; Lee, Hyunbeom; Kim, Dong-Wook; Park, Hyun Woo |